Genentech ยท 7 hours ago
2026 Summer Intern - Drug Metabolism and Pharmacokinetics
Genentech is a leading biotechnology company seeking a 2026 Summer Intern in Drug Metabolism and Pharmacokinetics. The intern will assist in research projects focusing on drug pharmacokinetics using physiologically-based pharmacokinetic modeling, while also summarizing and presenting findings to both experts and a general scientific audience.
BiotechnologyLife ScienceManufacturing
Responsibilities
Collate literature and internal data for demographic and biomarkers for lupus population
Build virtual Lupus population for PBPK simulations
Collate and summarize literature data for PK differences in lupus patients compared to healthy subjects
Simulate example drug PK in lupus patients and healthy subjects using PBPK and compare with clinical observations
Summarize and present research findings to both experts and general scientific audience
Qualification
Required
Must be pursuing a PhD (enrolled student)
Drug metabolism, pharmacokinetics, pharmaceutical sciences or related discipline
Solid understanding of pharmacokinetics, and how physiological and pathological factors impact drug metabolism and disposition
Strong research skills for literature mining and meta-analysis
Preferred
Experience with Simcyp or other PBPK software is preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Benefits
Paid holiday time off benefits
Company
Genentech
Genentech is a biotechnology research company that specializes in genetic testing and personalized medicines.
H1B Sponsorship
Genentech has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (167)
2024 (148)
2023 (150)
2022 (178)
2021 (121)
2020 (158)
Funding
Current Stage
Public CompanyTotal Funding
unknown2009-03-26Acquired
1999-07-20IPO
1976-01-01Series Unknown
Recent News
2025-12-30
Pharmaceutical Technology
2025-12-29
Pharmaceutical Technology
2025-12-24
Company data provided by crunchbase